Fig. 1: Summary of patient selection.

*Number of analyzable patients dependent on available data per guideline definition. AS active surveillance, PCa prostate cancer, MRI-TB magnetic resonance imaging - targeted biopsy, SB systematic biopsy.
*Number of analyzable patients dependent on available data per guideline definition. AS active surveillance, PCa prostate cancer, MRI-TB magnetic resonance imaging - targeted biopsy, SB systematic biopsy.